The article is available via Open Access. Click on the 'Additional link' above to access the full-text.Published version, accepted version (12 month embargo), submitted versio
Contains fulltext : 81201.pdf (publisher's version ) (Closed access
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018I...
International audienceObjective: Update the French Society for Rheumatology (SFR) recommendations on...
The article is available via Open Access. Click on the 'Additional link' above to access the full-te...
The article is available via Open Access. Click on the 'Additional link' above to access the full-te...
The aim of this guideline is to provide an update on evidence-based recommendations for treatment of...
The aim of this guideline is to provide an update on evidence-based recommendations for treatment of...
Background Psoriatic arthritis (PsA) is a clinically heterogeneous disease. Clear consensual treatme...
To update the 2011 Italian Society of Rheumatology (SIR) recommendations for the use of biologics an...
Since the publication of the European League Against Rheumatism recommendations for the pharmacologi...
The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use...
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non C...
The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use...
The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic...
To update the 2006 Italian Society for Rheumatology recommendations for the use of biologic (TNF-\u3...
Contains fulltext : 81201.pdf (publisher's version ) (Closed access
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018I...
International audienceObjective: Update the French Society for Rheumatology (SFR) recommendations on...
The article is available via Open Access. Click on the 'Additional link' above to access the full-te...
The article is available via Open Access. Click on the 'Additional link' above to access the full-te...
The aim of this guideline is to provide an update on evidence-based recommendations for treatment of...
The aim of this guideline is to provide an update on evidence-based recommendations for treatment of...
Background Psoriatic arthritis (PsA) is a clinically heterogeneous disease. Clear consensual treatme...
To update the 2011 Italian Society of Rheumatology (SIR) recommendations for the use of biologics an...
Since the publication of the European League Against Rheumatism recommendations for the pharmacologi...
The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use...
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non C...
The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use...
The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic...
To update the 2006 Italian Society for Rheumatology recommendations for the use of biologic (TNF-\u3...
Contains fulltext : 81201.pdf (publisher's version ) (Closed access
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018I...
International audienceObjective: Update the French Society for Rheumatology (SFR) recommendations on...